ChestEye Quality

JSON twin: https://www.healthaidb.com/software/chesteye-quality.json

Company Name

Oxipit

Product URL

https://oxipit.ai/products/chesteye/

Company URL

https://oxipit.ai

Categories

Summary

ChestEye Quality is an AI-powered tool that assists radiologists by analyzing chest X-ray images and reports to identify potential discrepancies, enhancing diagnostic accuracy and patient outcomes.

Description

ChestEye Quality is an AI-driven double-reading medical imaging tool developed by Oxipit. It analyzes final radiologist reports and corresponding medical images in near-real-time to identify reporting errors and improve patient outcomes. The platform operates in both retrospective and prospective modes, providing comprehensive quality assurance for chest X-rays, musculoskeletal X-rays, mammography studies, and CT scans. It integrates seamlessly into existing radiology workflows, offering quick deployment and minimal technical involvement from the client side. The system is fully GDPR compliant, anonymizing all identifiable data and operating onsite. Additionally, it supports multiple languages, accommodating diverse healthcare environments. Built upon the ChestEye Imaging Suite, ChestEye Quality covers 75 of the most common radiological findings, addressing over 90% of pathologies encountered daily in medical institutions. This extensive coverage enables the detection of subtle secondary findings, such as small pulmonary nodules, facilitating earlier detection of conditions like lung cancer. By providing a 'second set of eyes,' ChestEye Quality acts as a safety net, assisting radiologists in real-time and improving diagnostic performance. The platform has been deployed in multiple medical institutions across Europe, demonstrating its effectiveness in enhancing diagnostic accuracy and patient outcomes. Oxipit, the company behind ChestEye Quality, was founded in 2019 and is headquartered in Vilnius, Lithuania. The company has expanded its global reach, with deployments in various countries, including Brazil, where it secured ANVISA clearance for the ChestEye AI Suite in 2023. Oxipit continues to collaborate with international partners to further enhance the capabilities and accessibility of its AI diagnostic products.

Api Available

yes

Certifications

Company Founding

2019

Company Offices

Compliance

Customers

Data Residency

EU-only, US/EU regions, BYO cloud region

Data Standards

Deployment Model

Features

Id

SW0738

Integration Partners

Integrations

Languages Supported

Last Updated

2025-10-11

License

Commercial

Market Segment

Optional Modules

Os Platforms

Pricing Details

Contact vendor for pricing information.

Pricing Model

Subscription

Privacy Features

Product Code

SW0738

Product Name

ChestEye Quality

Ratings

Regions Available

Related Urls

Release Year

""

Security Features

Specialties

Support Channels

System Requirements

Target Users

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON